Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronotherapy for gastrointestinal cancers

F Lévi1

  • 1Laboratoire Rythmes Biologiques et Chronothérapeutique, I.C.I.G., Hopital Paul Brousse, Villejuif, France.

Current Opinion in Oncology
|July 1, 1996
PubMed
Summary

Chronotherapy, administering cancer drugs based on biological rhythms, improved treatment tolerance and response rates in patients with metastatic colorectal cancer. This timed approach enhances chemotherapy effectiveness and safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic syndrome and the risk of breast cancer in postmenopausal women.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

European cancer mortality predictions for the year 2011.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases.

The British journal of surgery·2011
Same author

Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis.

Medical oncology (Northwood, London, England)·2010
Same author

Variation in performance in low-volume mammography screening programmes: experience from Switzerland.

Cancer epidemiology·2010
Same author

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.

British journal of cancer·2010

Area of Science:

  • Oncology
  • Pharmacology
  • Chronobiology

Background:

  • Cancer chemotherapy efficacy and toxicity vary with dosing time.
  • Circadian rhythms influence drug metabolism and cell proliferation.
  • Advancements in drug delivery systems enable precise chronotherapy.

Purpose of the Study:

  • To demonstrate the clinical relevance of chronotherapy in cancer treatment.
  • To evaluate a chronomodulated three-drug regimen for metastatic colorectal cancer.
  • To assess the impact of timed drug administration on chemotherapy tolerance and efficacy.

Main Methods:

  • Utilized portable programmable multi-channel pumps for 5-day infusions.
  • Administered 5-fluorouracil, leucovorin, and oxaliplatin based on circadian rhythms.
  • Conducted a Phase III clinical trial comparing flat versus chronomodulated regimens in over 1000 patients.

Main Results:

  • Chronotherapy significantly improved chemotherapy tolerance and allowed dose escalation.
  • Simultaneous improvements in tolerability and response rates were observed.
  • The chronomodulated regimen demonstrated superior outcomes in metastatic colorectal cancer patients.

Conclusions:

  • Chronotherapy offers a safe and effective approach to cancer treatment, enhancing drug efficacy and patient tolerance.
  • This timed drug delivery strategy is beneficial for gastrointestinal malignancies and can be combined with other therapies.
  • Integrating chronopharmacology early in drug development, as with oxaliplatin, maximizes therapeutic benefits and patient safety.

Related Experiment Videos